HWP will continue moving up next week. Trading zone: $62-$66. The idea of DELL buying HP is as laughable as Mexico buying USA. This company has tremendous brain power. Some of the HP products makes you think probably Martian people work there. HP is working on a number of projects that will bring lots of money in the future.It is now sowing the seeds. you will reap the harvest later. So do not waste your time thinking someone will buy HP. The price is low now, so buy HWP as much as you can. The future of technology is bright. How do you spell technology? HWP.
<Picture><Picture: Get your free Schwab IRA Answers Kit><Picture><Picture: S&P's PERSONAL WEALTH><Picture: search><Picture: help><Picture: info desk><Picture: trade> <Picture: quote><Picture: market snapshot><Picture: pw today><Picture> <Picture> <Picture> <Picture> <Picture: Markets><Picture><Picture><Picture><Picture: Market Snapshot>MarketMovers <Picture>Word on the Street <Picture>STARS Picks and Pans <Picture>NewsStand <Picture>MarketViews <Picture>The Outlook's Market Insight <Picture>Technical Market Insight <Picture>S&P's Market Month Review <Picture>Quarterly Market Outlook <Picture><Picture: World Equity Watch><Picture: Treasury Market Watch><Picture: Currency Market Watch><Picture: Commodity Markets Watch><Picture: BankTeller><Picture><Picture>�MARKETS : MARKET SNAPSHOT � <Picture: STARS Picks and Pans> <Picture> <Picture><Picture> <Picture>
Friday March 20, 1998 (3:45 pm EST)
S&P Analysts' Comments - 3/20/98
S&P analyst Megan Graham-Hackett continues to recommend investors accumulate Hewlett-Packard (HWP) and Sun Microsystems (SUNW) after the Wall Street Journal reported that HWP plans to market its own version of Sun's Java software for electronic devices. She believes that while HWP's move could be a psychological blow to Sun's Java stronghold, it is not likely to have a material impact on either company's earnings.
S&P analyst Herman Saftlas reiterated a buy on Guidant Corp (GDT) and raised his 1998 earnings per share estimate for the company after it told him that it plans to file its new DUET coronary stent with the FDA in the second quarter. He also noted that GDT just released its new Ventak AV II DR implantable cardioverter defibrillator, the first to incorporate dual-chamber adaptive rate pacing capability.
S&P analyst Maureen Carini maintains avoid ratings on Philip Morris Cos (MO) and UST Inc (UST) and a hold on RJR Nabisco Holdings (RN) after an Indiana court ruled that cigarette makers are not liable for the death of non-smoking nurse. She still believes investors should exercise caution until the outcome of the national tobacco settlement is finalized.
20-MAR-98 15:45:05�(01070307)��Copyright 1998 Standard & Poor's Investment Advisory Services, Inc. The information contained in this report may not be published, broadcast, rewritten or otherwise distributed without prior written consent from Standard & Poor's. For permission call 1-212-770-4639.
<Picture><Picture>� � 1998 Standard & Poor's Investment Advisory Services, Inc. Quotes are delayed up to 20 minutes. By accessing and using this page, you agree to the Terms of Service. � <Picture><Picture><Picture>